Inavolisib 3mg, 9mg Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 3mg, 9mg
Reference Brands: Itovebi (USA/EU)
Category: Critical Care
Inavolisib is a targeted oral PI3K-alpha inhibitor used in combination with palbociclib and fulvestrant for treating PIK3CA-mutated, hormone receptor-positive, HER2-negative advanced breast cancer. It not only inhibits the mutated PI3Kα enzyme but also promotes its degradation, selectively acting on cancer cells with PIK3CA mutations. The drug has shown strong efficacy in prolonging progression-free survival in clinical trials.
Inavolisib — third party manufacturing & bulk supply
Inavolisib 3mg, 9mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Inavolisib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Inavolisib →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Inavolisib is used in combination with palbociclib and fulvestrant to treat adults with hormone receptor–positive, HER2-negative advanced or metastatic breast cancer that carries a PIK3CA mutation. It is specifically indicated for patients whose disease has become resistant to endocrine therapy.
Inavolisib is made from the active substance inavolisib, a selective PI3K-alpha inhibitor. It works by blocking and degrading the mutant PI3K-alpha enzyme, which helps stop cancer cell growth in tumors driven by PIK3CA mutations.
The trade name of inavolisib is Itovebi.
Inavolisib (Itovebi) is developed and manufactured by Roche/Genentech.
The generic name is inavolisib.
The brand name is Itovebi.
Inavolisib is manufactured by Roche/Genentech at their approved global pharmaceutical production facilities, depending on regional supply requirements.
Related Products
Ringer's Lactate
Strength:
100 mL, 250 mL, 500 mL, 1000ml
Form: Infusion
Reference Brands: Generic formulations marketed under different names
View Details
Rolapitant Hydrochlorid
Strength:
90 mg
Form: Tablets
Reference Brands: Varubi(USA/LATAM), Varuby(EU)
View Details
Conivaptan Hydrochloride
Strength:
20 mg/100 mL
Form: Infusion
Reference Brands: Vaprisol (USA)
View Details
Fitusiran
Strength:
50 mg/0.5 ml, 20 mg/0.2ml
Form: injection (prefilled syringe)
Reference Brands: Generic formulations marketed under different names
View DetailsQuick Response Guaranteed | Verified Suppliers
